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1346Objective: We have previously reported the use of an atriopericardial or ‘‘sutureless’’ repair for surgical man-
agement of postoperative pulmonary vein stenosis. The potential of avoiding geometric distortion of pulmonary
venous suture lines and preventing post-repair pulmonary vein stenosis encouraged us to extend the use of this
technique for primary ‘‘simple’’ total anomalous pulmonary venous connection repair.
Methods: Between January 1997 and July 2009, 57 consecutive patients (median age, 15 days; median weight,
3.4 kg) underwent sutureless or conventional total anomalous pulmonary venous connection repair.
Results: Types of total anomalous pulmonary venous connection included supracardiac in 31 patients (54%),
cardiac in 15 patients (26%), and infracardiac in 11 patients (19%). Median follow-up time was 2.9 years. Pre-
operative mean pulmonary vein score, a composite measure of stenosis in all 4 pulmonary veins, was 0.3/0–12,
and vertical vein obstruction was found in 35 patients (61.4%). A primary sutureless repair was carried out in 21
patients (36.8%; supracardiac, n¼ 12; cardiac, n¼ 4; infracardiac, n¼ 5). The sutureless repair group had pro-
portionally greater high-risk infracardiac total anomalous pulmonary venous connection (24% vs 16%,
P ¼ .05). Primary outcomes of death or reoperation for pulmonary vein stenosis and postoperative pulmonary
vein scores (0.2  0.7 vs 0.7  1.7, P ¼ .26) were not different between the techniques.
Conclusions: The sutureless repair group had proportionally more infracardiac total anomalous pulmonary ve-
nous connection and a higher rate of decline in postoperative right ventricular systolic pressure. Despite in-
creased preoperative risk, no difference was observed in primary outcomes of death and reoperation in the
conventional repair group. (J Thorac Cardiovasc Surg 2011;141:1346-54)Earn CME credits at
http://cme.ctsnetjournals.org
Total anomalous pulmonary venous connection (TAPVC) is
a congenital anomaly in which all 4 pulmonary veins do not
connect directly to the left atrium. The 2 major risk factors
for hospital mortality after surgical repair are pulmonary hy-
pertension and development of pulmonary venous obstruc-
tion. Pulmonary venous obstruction can occur at the level of
the pulmonary venous confluence to atrial connection or in
the pulmonary veins.1,2 Reports in the last few years have
shown overall hospital mortality ranging from 2% to 18%
after TAPVC repair.3-7 Stenosis of pulmonary venous
drainage is reported to occur in 6% to 9% of cases aftere Divisions of Cardiac Surgerya and Cardiology,b Labatt Family Heart Centre,
ospital for Sick Children, University of Toronto, Toronto, Ontario.
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The Journal of Thoracic and Cardiovascular Surrepair of TAPVC and is particularly prevalent with young
age at initial surgery, infracardiac connection type, and
preexisting pulmonary vein stenosis (PVS).5,6,8 Our group
and others have previously described an atriopericardial
connection repair for recurrent PVS that uses the
pericardium in situ to create a neo left atrium. There are no
suture lines on the native pulmonary vein tissue.5,9 The
repair is referred to as ‘‘sutureless’’ because there is no
direct atrial to pulmonary vein or pulmonary venous
confluence anastomosis. We use the terms ‘‘atriopericardial’’
repair and ‘‘sutureless’’ repair interchangeably. A potential
advantage to this technique is a more limited reactive
intimal proliferation because the suture line is not directly
on the pulmonary vein. There are also advantages with
respect to no direct suture line distortion or narrowing of the
veins, particularly if they are small. Optimal flow
characteristics for a given vein are therefore intact.
After repair of TAPVC, post-repair pulmonary venous
stenosis can occur. Our group previously showed that the
use of sutureless repair for post-repair PVS improved sur-
vival and reduced the need for reintervention for
PVS.10,11 Most of our previous discussion on this topic
has focused on de novo PVS, after repair of TAPVC, and
some primary sutureless repair of TAPVC in the case of
right atrial isomerism. A few of the patients presented in
this study were briefly mentioned and embedded withingery c June 2011
Abbreviations and Acronyms
ECMO ¼ extracorporeal membrane oxygenation
LA ¼ left atrial
LAVi ¼ indexed left atrial volume
mPAP ¼ mean pulmonary artery pressure
PVS ¼ pulmonary vein stenosis
RVSP ¼ right ventricular systolic pressure
TAPVC ¼ total anomalous pulmonary venous
connection
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various pathology of the pulmonary veins.11 The current re-
port focuses on the primary use of an atriopulmonary con-
nection for ‘‘simple’’ TAPVC.
Our initial ‘‘primary use’’ of sutureless repair was in
1998 in a case of infracardiac TAPVC with severe obstruc-
tion and a small pulmonary venous confluence. After conven-
tional repair, a residual mean gradient of 2 mmHg was found
in all 4 pulmonary veins that did not resolvewith revision. The
child required extracorporeal membrane oxygenation
(ECMO) support and could not be weaned 6 days later be-
cause of high mean pulmonary artery pressure (mPAP). The
anastomosis was revised to a sutureless technique, and the pa-
tient was weaned from cardiopulmonary bypass with resolu-
tion of the gradient. Since that time, we have used an
atriopericardial connection for all infracardiac TAPVCs.
Our practice technique with regard to supracardiac and
some cardiac TAPVCs, with mild obstruction at the connec-
tionof the confluence to thecoronary sinus, hasbeen evolving.
The rationale for an atriopericardial connection is to
eliminate potential distortion or narrowing of the pulmo-
nary veins for optimal flow characteristics for a given vein
or confluence. Because post-repair pulmonary venous ob-
struction has been effectively managed with an atriopericar-
dial connection, a second rationale is that it might prevent
the development of post-repair PVS. We present our mid-
term results comparing outcomes of the atriopericardial
procedure with a conventional repair for a subset of ‘‘sim-
ple’’ TAPVC during an interval of practice evolution. Out-
comes with respect to mortality and development of
pulmonary venous obstruction are evaluated.PATIENTS AND METHODS
Patient Data
Data on patients with isolated TAPVCwere collected at the Hospital for
Sick Children, University of Toronto, between January 1997 and July
2009. Those with the following conditions were excluded: associated con-
genital cardiac lesions, such as right atrial isomerism and hypoplastic left
heart syndrome, mixed-type TAPVC, syndromic, and single ventricle. We
identified 57 consecutive patients with ‘‘simple’’ TAPVC. Ethics approval
from our institutional review board was obtained. Patient demographic,
operative and postoperative records, clinic notes, and echocardiographicThe Journal of Thoracic and Carimaging were studied. Baseline patient characteristics are listed in
Table 1. The median age at time of initial surgical intervention was 15
days (range, 1–1157 days) and median weight was 3.4 kg (1.7–11.7 kg).
Median follow-up was 2.9 years (range, 5 days to 11.7 years). Patients
from earlier study years (1997–2004) were more likely to be repaired pri-
marily with a conventional approach, and patients from later study years
(2005–2009) were more likely to be repaired primarily with a sutureless
repair (Figure 1).
Pulmonary Vein Score
The pulmonary vein score for each individual vein was calculated as
previously reported.11 Briefly, pre- and postoperative echocardiographic
data were reviewed to quantify the degree of PVS: 0 ¼ no stenosis
(mean gradient< 2 mm Hg); 1 ¼ mild stenosis (mean gradient 2.0–6.9
mm Hg); 2 ¼ severe stenosis (mean gradient >7 mm Hg); and
3 ¼ complete occlusion. The sum of the individual pulmonary vein scores
is then used as a subjective measure of the overall degree of PVS ranging
from 0 (no stenosis) to a theoretic maximum score of 12.
Echocardiographic Measurements
Echocardiographic images were evaluated in a blinded manner for type
of repair and outcome. Right ventricular systolic pressure (RVSP) was
evaluated using the tricuspid regurgitant jet, and mPAP was estimated
from the early diastolic velocity of the pulmonary regurgitant jet. For
both measurements, the modified Bernoulli equation was used. Left ven-
tricular ejection fraction was measured from M-mode or 2-dimensional
measurements of left ventricular end-diastolic and end-systolic dimensions
using the Teichholz formula. Indexed left atrial volume (LAVi) was mea-
sured as 0.85*left atrial (LA) area in apical 4-chamber view*LA area in
apical 2-chamber view/LA length/body surface area, as described previ-
ously.12 The collecting chamber was included in the LA volumetric mea-
surement in the postoperative study. Mean gradients of the Doppler
traces of the individual pulmonary veins were also measured.
Statistical Analysis
Data are presented as frequencies, medians with ranges, or means with
standard deviations. Survival data are represented by the Kaplan–Meier
survival curve. Longitudinal data analysis was performed using mixed-
effects models for analysis and to generate a graphic display of the aver-
aged trend lines for the echocardiographic data. Statistical analyses were
performed using SAS (Version 9.1; SAS Institute Inc, Cary, NC) and R
(Version 2.10, R Project for Statistical Computing).
Surgical Technique
Surgical repair was performed on cardiopulmonary bypass (mean time,
88.0 31.0 minutes) with bicaval cannulation. For cardiac TAPVC (n¼ 15
in total), the coronary sinus was unroofed in the conventional repair group
(n¼ 11) and further included single- or 2-sided atriopericardial connection
in the sutureless repair group (n¼ 4) if there was associated vein to conflu-
ence orifice stenosis. For sutureless repair of infracardiac and supracardiac
TAPVC, incisions were made in the venous confluence and then extended
into both upper and lower pulmonary veins separately if judged to be im-
portant for unobstructed flow (Figure 2). Small pulmonary venous conflu-
ences (ie, smaller than the normalized mitral valve size diameter), such as
those seen in infracardiac TAPVC, were more likely to require incisions in
the individual pulmonary veins out toward the pleural pericardial reflec-
tion. An atriopericardial anastomosis was created using the pericardium ad-
jacent to the pulmonary vein entrance to the pericardium. A neo left atrium
was thus created. The atriopericardial anastomosis avoids direct contact
with the vein wall incision site and allows the free egress of blood from
the lungs into the left atrium (Figure 2). The atrial septal defect or patent
foramen ovale was closed or partially closed. Other details have been de-
scribed in our previous report.11diovascular Surgery c Volume 141, Number 6 1347
TABLE 1. Patient preoperative, operative, postoperative, and outcomes data
Variable
Preoperative
Conventional repair Sutureless repair
Overall Supracardiac Cardiac Infracardiac Overall Supracardiac Cardiac Infracardiac
N 36 19 11 6* 21 12 4 5*
Age (d) 19 (1–1157) 21 (0–387) 46 (0–1157) 3 (1–19) 11 (1–138) 5.5 (0–72) 64 (11–138) 20 (1–23)
Weight (kg) 3.5 (1.7–11.7) 3.4 (2.4–6.5) 3.6 (2.7–11.7) 3.1 (1.7–4.1) 3.3 (1.9–5) 3.5 (2.3–5.1) 3.0 (1.9–4.4) 3.2 (2.7–3.9)
PVS 0.2  1 0.3  1.4 0.0  0.0 0.2  0.4 0.5  1.2 0.3  1.2 1.5  1.9 0.0  0.0
Male (%) 55 52.6 45.5 45.5 57 50.0 100.0 18.2
LVEF (%) 66.3  10.1* 70.6  10.8 61.9  8.4* 61.8  5.1* 74.5  7.2* 72.0  8.9 76.8  2.2* 78.0  4.6*
LAVi 5.9  3.1 5.9  3.1 7.1  3.4 3.6  1.5 4.8  3.4 4.2  2.5 8.5  5.0 2.9  0.8
Vertical vein
obstruction
18 (50%)* 9 (47.4%)* 3 (27.3%)* 6 (54.5%)* 17 (81%)* 11 (91.7%)* 4 (100%)* 5 (45.5%)*
Operative
CPB time 84.5  34.6 98.2  38.9 69.8  27.8 72.7  15.8 93.8  23.2 84.3  11.6 111.8  22.2 100.4  35.2
Crossclamp time 48.8  22.4* 56.9  25.9 39.4  16.0 42.3  11.5* 62.3  19.3* 56.5  17.7 69.8  23.6 70.6  18.7*
DHCA time 4.5  10.9* 0.7  2.8* 6.2  14.4 13.2  15.0 15.9  19.2* 11.3  16.0* 5.5  11.0 35.4  20.3
Postoperative
Pulmonary vein score 0.7  1.7 0.3  1.0 1.0  1.4 1.3  3.2 0.2  0.7 0.3  1.0 0.0  0.0 0.7  1.2
Mean PAP (mm Hg) 23.8  13.7 28.7  18.7 34.3  26.6 – 28.3  12.5 0.0  0.0 – 22.5  10.6
RVSP (mm Hg) 33.5  13.3 35.4  10.0 34.4  26.6 20.5  3.5* 40.5  11.8 42.7  15.0 35.0  9.9 40.0  6.6*
LVEF (%) 69.3  6.2 69.9  6.7 37.0  5.9 67.3  6.2 67.1  9.7 65.0  11.0 73.0  7.5 68.6  6.3
LAVi 15.8  6.5 15.9  6.3 18.9  6.9 11.1  4.2 14.8  5.7 13.3  5.2 20.8  6.2 14.7  5.1
Length of hospital
stay (d)
10 (2–195) 13.0 (5–75) 9.0 (2–195) 16 (8–108) 17 (7–112) 13.5 (7–112) 17.5 (7–63) 19 (9–60)
Outcomes
Follow-up time (d) 45.8
(0–143.1)*
47.0
(0.3–131.1)
34.7
(0.3–137.3)
53.7
(0–143.1)
21.1
(0.2–104.8)*
46.8
(1.8–99.7)
12.5
(0.2–30.2)
19.8
(0.2–104.8)
Reoperation 2 (5.5%) 1 (4.7%) 0 (0%) 1 (16.7%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Cardiac death 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (8.3%) 1 (25%) 0 (0%)
Noncardiac death 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (9%) 0 (0%) 0 (0%) 0 (0%)
LVEF, Left ventricular ejection fraction; LAVi, indexed left atrial volume; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; PAP, pulmonary artery
pressure; PVS, pulmonary vein stenosis; RVSP, right ventricular systolic pressure. *P<.05.
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Preoperative
A total of 57 patients were included in this series, of
whom 36 underwent conventional repair and 21 underwent
sutureless repair. Preoperative vertical vein stenosis was
more common in the sutureless repair group compared
with the conventional repair group (81% vs 50%,
P ¼ .02). However, pulmonary venous obstruction (pulmo-FIGURE 1. Number of conventional versus sutureless repairs performed
by year at the Hospital for Sick Children. TAPVC, Total anomalous pulmo-
nary venous connection.
1348 The Journal of Thoracic and Cardiovascular Surnary vein score; 0.5  1.2 vs 0.2  1.0, P ¼ .38) and LAVi
were not significantly different between the groups (4.8 
3.4 vs 5.8  3.1, P ¼ .25). Other preoperative characteris-
tics were similar between the sutureless and conventional
repair groups (Table 1).
Operative
Total cardiopulmonary bypass time was similar in both
groups. However, crossclamp and circulatory arrest times
were longer in the sutureless repair group (P ¼ .02; Table
1). The longer crossclamp and deep hypothermic circula-
tory arrest times for sutureless repair were most likely re-
lated to surgeon bias because the surgeon who performed
the majority of sutureless repairs chose to do so with circu-
latory arrest. When separated into TAPVC types, cross-
clamp times were longer in infracardiac sutureless repair
compared with conventional repair (70.6  18.7 vs 42.3
 11.5, P< .05), which may reflect greater preoperative
anatomic complexity.
Postoperative
Postoperative characteristics were not significantly dif-
ferent between the 2 groups with regard to total pulmonarygery c June 2011
FIGURE 2. Surgical repair for TAPVC. Conventional repair, conventional repair (pulmonary vein insert with potential suture line stenosis), and sutureless
repair (pulmonary vein insert) techniques are shown. TAPVC, Total anomalous pulmonary venous connection.
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similar (Table 1).
The overall RVSP was not significantly different; how-
ever, in the infracardiac repair group, the RVSP was higher
in the sutureless repair group (20.5  3.5 vs 40.0  6.6,
P<.05), likely reflective of higher grade preoperative ob-
struction. Averaged trend lines for the longitudinal echocar-
diographic RVSP are similar between the 2 groups
(Figure 3). Multivariable regression analysis revealed that
patients with sutureless repair had higher RVSP than aver-
age baseline (P ¼ .003), and this decreased at a higher lin-
earized rate than in thosewith conventional repair (P¼ .02).
Among patients who were selected for sutureless repair,
those with cardiac TAPVC had higher RVSP at baseline
compared with supracardiac TAPVC (P ¼ .002). The line-
arized rate of decline in RVSP over time in patients who un-
derwent sutureless repair tended to be slower in patientsFIGURE 3. Longitudinal averaged trends for RVSP. Patients with TAPVC in th
serial postoperative RVSP.
The Journal of Thoracic and Carwho underwent infracardiac TAPVC versus cardiac TAPVC
(P ¼ .05), and versus supracardiac TAPVC (P ¼ .02). We
found no differences in the overall rate of decline in
mPAP and ejection fraction percent pre- and postopera-
tively in both repair groups. There were no significant dif-
ferences in pulmonary vein score pre- and postoperatively
in both repair groups.
Outcomes
Median follow-up time was 45.8 (0–143.1) months in the
conventional repair group and 21.1 (0.2–104.8) months in
the sutureless repair group. Two patients in the conventional
repair group underwent reoperation for PVS (5.5%;
Figure 4). Unilateral pulmonary vein occlusion developed
in 1 patient who underwent cardiac TAPVC in the sutureless
repair group, but this patient did not undergo reoperation
(RVSP 45, mPAP 32). Two patients in the sutureless groupe conventional and sutureless repair groups were compared with respect to
diovascular Surgery c Volume 141, Number 6 1349
FIGURE 4. Freedom from reoperation. Patients with TAPVC in the conventional and sutureless repair groups were compared with respect to freedom from
reoperation.
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related to a tracheoesophageal fistula repair, and one died
of pulmonary hypertension at 10 months of age, which per-
sisted despite documented nonobstructed pulmonary veins
(3.8%). One infant in the sutureless repair group required
a permanent pacemaker for complete heart block. There
were no cardiac causes of death in either repair group in
our series. Overall mortality or repair failure (overall death
or reoperation) was not statistically significant between the
2 groups (Figure 5).Comment
As in most biventricular repair-type congenital anoma-
lies, early mortality has substantially declined for TAPVC.
In a subset, early post-repair pulmonary hypertension and
lung function still remain a challenge. Late mortality related
to pulmonary venous stenosis has not been eliminated. ForFIGURE 5. Freedom from reoperation or death. Patients with TAPVC in the
freedom from reoperation and all-cause mortality.
1350 The Journal of Thoracic and Cardiovascular Surthose with infracardiac TAPVC with very small pulmonary
veins and pulmonary venous confluences, achieving a repair
that has no distortion or even limited stenosis can be chal-
lenging. A direct suture line on very small pulmonary veins
or a small confluence can leave distortion or minor gradi-
ents (Figure 2). Strategies to address the technical problems
of post-repair pulmonary venous obstruction for small con-
fluences and veins have been the creation of a generous-
sized pulmonary venous confluence to LA anastomosis
and the use of interrupted or absorbable sutures that extend
into the individual pulmonary veins (Figure 2). Small
pulmonary vein gradients remain in some patients and can
be a significant physiologic burden because of secondary
pulmonary hypertension.
Our exploration of the sutureless repair strategy for ob-
structed infracardiac TAPVD first occurred in an attempt
at a salvage procedure for a failed conventional repair inconventional and sutureless repair groups were compared with respect to
gery c June 2011
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cessful application of the sutureless technique in that patient
and the recognized potential benefits of not having an anas-
tomosis on the small confluence or veins led to a subsequent
deliberate strategy to use the technique for small conflu-
ences and veins. We rationalized that by eliminating anasto-
motic distortion to the pulmonary veins, post-repair lung
function and early pulmonary hypertension may be better
managed. The indications to use the technique in larger
veins and confluences were liberalized according to the sur-
geon’s judgment for a better technical outcome.We also ob-
served that the atriopericardial suture line can be technically
easier to perform, particularly if the veins or confluence are
borderline or small in size.
Because of the low incidence of occurrence for this dis-
ease, the total numbers and events in this study are relatively
small. The associated small number of event end points
leads to little statistical power. By univariate analysis, how-
ever, despite a greater proportion of infracardiac TAPVC,
there was no demonstrable difference in early and late mor-
tality. Previous data have shown that preoperative pulmo-
nary vein obstruction was a risk factor for mortality and
development of late PVS. Onemight hypothesize, therefore,
that the lack of difference in outcomes data for a higher-risk
population is favorable. Our current indications for suture-
less repair are (1) all infracardiac TAPVC, (2) intracardiac
TAPVC with evidence of pulmonary vein stenosis, and (3)
surgeon preference for supracardiac TAPVC.
Preoperative and Postoperative Pulmonary Venous
Obstruction
Preoperative pulmonary venous obstruction has been as-
sociated with significant mortality in the context of
TAPVC.4,6,9,13,14 Jenkins and colleagues15 reported that in-
dividual pulmonary vein diameter and small vein conflu-
ence were significant predictors of survival in patients
with TAPVC. Although contemporary overall hospital
mortality for TAPVC repair ranges from 2% to 18%, it
increases to 30% to 66% in the presence of recurrent
pulmonary vein stenosis.1,3-7 The present study found no
difference in pulmonary vein scores between the
sutureless and conventional repair groups (0.5/12 vs 0.2/12).
The reported incidence of postoperative PVS varies from
1% to 18%, with larger series showing an incidence of 6%
to 9%.6,8,14-16 A previous study from our institution found
reoperation for PVS to be associated with young age at
initial surgery, cardiac connection type, and existing
pulmonary venous obstruction.11 In the present study, 21
patients (36.8%) underwent operation within 1 week of
birth, 15 patients (26.3%) had cardiac connection-type
TAPVC, and 5 patients (8.8%) had some degree of preop-
erative PVS.
Two patients in the conventional repair group required re-
operation: the index patient and a patient who underwentThe Journal of Thoracic and Carconventional repair for a large confluence nonobstructed
supracardiac TAPVC in whom stenosis developed in the
first few months after repair. Unilateral pulmonary vein ob-
struction with retrograde stenosis into the lung developed in
1 patient in the sutureless group. The pulmonary pressures
were mildly elevated. No operation was performed. No pa-
tient in this series died of pulmonary venous obstruction.
Pulmonary Hypertension
Persistent pulmonary hypertension is a common postop-
erative complication after TAPVC repair, particularly in the
setting of pulmonary venous obstruction.17 Treatment may
include medical therapy, such as nitric oxide, mechanical
resuscitation with ECMO or surgical revision, or septos-
tomy. Failed repair or recurrence can lead to mortality or
the requirement of lung or heart–lung transplantation.18
By multivariate analysis, patients in the sutureless repair
group had higher preoperative RVSP, which decreased at
a higher rate than in those in the conventional repair group.
This is a potential explanation for the ability to manage the
pulmonary hypertension without the need for ECMO in re-
cent years. Immediate postoperative RVSP was 2 times
higher in the infracardiac TAPVC group with sutureless re-
pair compared with conventional repair despite having
lower postoperative pulmonary vein scores. We suspect
this occurred because the sutureless repair group had worse
preoperative obstruction. Notably, once the policy to use su-
tureless repair was instituted, we did not require the use of
ECMO for pulmonary hypertension in any further patients.
With time, the early elevated RVSP in the sutureless repair
group was lower than in the conventional repair group, im-
plying that a satisfactory anatomic outcome was achieved.
Left Atrial Size
We measured LA size, hypothesizing that a more benign
postoperative course, with respect to cardiac and pulmonary
function issues related to pulmonary hypertension, might be
explained by a potential LA enlargement from the atrioper-
icardial connection. No difference in atrial size was demon-
strated between the operative strategies.
Potential Risks in Sutureless Repair
There is potential risk in anatriopericardial repair, including
(1) thrombogenicity at the exposed pericardial surface, (2) air
embolism, (3) soft tissue rupture, and (4) phrenic nerve injury.
We have anticoagulated some patients using low-
molecular-weight heparin when therewas concern of poten-
tial clot formation from raw posterior mediastinal tissue that
is sometimes exposed and incorporated into the left atrium
in an atriopericardial connection. Although the connection
is hemostatic, the pulmonary venous confluence is not in
direct contact with the suture line. Therefore, hemostasis
is dependent on the integrity of the posterior mediastinum
and pleural pericardial junction. A breach in the integritydiovascular Surgery c Volume 141, Number 6 1351
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a complication that may be managed by intrapleural hilar
approximation.11 In general, use of primary atriopericardial
anastomosis, as opposed to its use for pulmonary venous
stenosis, does not require as aggressive an incision into
the individual pulmonary veins. The risk of intrapleural
bleeding should therefore be less than that seen in de
novo pulmonary venous stenosis sutureless repairs.
We have some concern regarding closed-chest compres-
sion in the event of need for postoperative cardiopulmonary
resuscitation. We would prefer to perform open chest mes-
sage if cardiopulmonary resuscitation is required. Our ratio-
nale is that closed chest compression could result in pleural
rupture and lead to atriopleural exsanguination. We believe
the risk is low, unless there is an aggressive incision into the
subpleural portion of individual pulmonary veins. Phrenic
nerve injury and diaphragmatic paralysis are risks. The
present cohort did not have phrenic nerve injury.
After assembling these data, we performed a sutureless
repair on a neonate with mixed-type obstructive TAPVC.
High mean airway pressure oscillation ventilation was re-
quired postoperatively. Cardiac arrest necessitated ECMO.
At ECMO initiation, air bubbles were found in the aorta,
which we suspect was related to mediastinal air induced
by the high ventilation pressures. In this particular case,
a distal incision into the individual veins within the pulmo-
nary parenchyma had been made because of their small
size. The distal incision may have raised the risk of medias-
tinal air tracking into the left atrium. The child survived
without neurologic sequelae.19
Limitations
Limitations of this study are the retrospective nature,
small study population, and small number of events. We
demonstrate potential trends that will bear further analysis
and that may prove to be statistically significant given
a larger sample size. Specifically, we found potential trends
in higher preoperative pulmonary vein score, RVSP, and
LAVi despite lower values after sutureless repair. Finally,
there may be an era effect because patients from earlier
study years (1997–2004) were repaired primarily with
a conventional approach and patients from later study years
(2005–2009) were repaired primarily with a sutureless
approach.
CONCLUSIONS
Sutureless repair for TAPVCwas effective in relief of pul-
monary venous obstruction. Development of late pulmonary
venous obstruction was not different between sutureless and
conventional repair patients. No patient died of pulmonary
venous obstruction. The sutureless repair group had propor-
tionally more infracardiac TAPVC and a higher rate of
decline in postoperative RVSP. Despite increased preopera-
tive risk, no difference was observed in primary outcomes1352 The Journal of Thoracic and Cardiovascular Surof death and reoperation in the conventional repair group,
suggesting that application of the technique to high-risk pa-
tients may be beneficial. The sutureless technique is a useful
addition to the surgeon’s armamentarium, particularly for
repair of difficult cases, such as infracardiac TAPVC.References
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DDiscussion
Dr Francois Lacour-Gayet (New York, NY). Primary repair of
total abnormal pulmonary venous return using the sutureless tech-
nique is extremely appealing, and your experience in Toronto shows
excellent results. The conventional repair results in terms of mortal-
ity andmorbidity have significantly improved.We have found it best
to use a technique that does not manipulate the pulmonary vein.
Nevertheless, some anatomic forms remain at risk. They include,
as youmentioned, the small pulmonary vein confluence in the infra-
cardiac type, the mixed venous forms, and, for an unknown reason,
the total vein associated with a single ventricle. I have a few
questions.
In view of the good results you have observed, would you con-
sider using the primary sutureless technique for miscellaneous and
single ventricle forms, the total pulmonary resistance associated
with heterotaxy-type single ventricle?
Dr Alghamdi. In our previously published report, sutureless re-
pair was used as a primary procedure for PVS associated with
TAPVD and isomeric atrial arrangement. Most of these patients
had right atrial isomerism. Some patients also had a single ventri-
cle. The results were encouraging. These patients were excluded
from this cohort.
Dr Lacour-Gayet.One advantage of the technique is to be able
to safely open the trunk of the pulmonary vein with minimal risk of
stenosis. Do you always incise the pulmonary vein trunks using
this technique?
Dr Alghamdi. The extension of the incision of the pulmonary
venous confluence to the individual pulmonary veins will be ap-
plied if there is documented preoperative PVS or the pulmonary
veins are small on the subjective intraoperative assessment. There-
fore, extension of the incision to the individual veins is not done
routinely.
Dr Lacour-Gayet. I have seen in your series that you report us-
ing the technique in the intracardiac form. The application of the
technique to intracardiac form seems more challenging because
by definition the pulmonary veins are attached to the heart by
the width of the coronary sinus. Furthermore, the operation to un-
roof the coronary sinus and patch from the coronary sinus to the
atrial septal defect is, in a way, already a sutureless technique.
Would you comment on your experience in applying the sutureless
technique to intracardiac types?
Dr Alghamdi. Performing the sutureless technique for the car-
diac-type TAPVC is only performed when the unroofing of the cor-
onary sinus is not adequate (ie, when there are documented small
pulmonary veins).
Dr Lacour-Gayet. Finally, the occurrence of pulmonary vein
obstruction after a repair seems unpredictable and could be in re-
lation to an abnormal metabolism of the native pulmonary venous
endothelium. In the situation in which a pulmonary venous ob-
struction occurs despite a perfect primary sutureless repair, you
will be left with no ammunition to repair the pulmonary vein ob-
struction. Do you consider that this limitation could be a reason
for elective primary sutureless repair only to the adverse form?
Dr Alghamdi. Can you repeat that again?
Dr Lacour-Gayet.While considering that once you have done
the repair, you cannot do it again, the question is, if it happens de-
spite an excellent surgery, won’t you then be left with the only op-
tion of giving the patient to the cardiologist? And my question is,The Journal of Thoracic and Carfor the simple form, knowing that even with an excellent technique
you sometimes can have pulmonary vein obstruction, it’s not bad
to have this ammunition ready.
Dr Alghamdi. PVS will develop in some patients, despite what
is considered a ‘‘perfect’’ repair. We propose though, that the su-
tureless technique minimizes the ‘‘trigger’’ for the development
of PVS. Although the sutureless technique does not abolish the
risk of PVS, it is associated with a low incidence of PVS, which
is a reasonable justification to use it up-front.
Dr Lacour-Gayet. I want to congratulate the group in Toronto
for this innovative technique. It will be useful to elective patients.
Dr Peter Manning (Cincinnati, Ohio). Just a quick technical
question regarding bleeding complications. In a primary repair
such as this, the planes behind the pericardium may not be as
well socked in as in a child in whom PVS has developed after
a prior operation. One experience that we have had using this tech-
nique in a child with infracardiac total veins as a primary proce-
dure was bleeding, where the blood dissected from our newly
created space down to the area where we had dissected and ligated
the vertical vein. Do you avoid, particularly in the infracardiac
cases, dissecting the vertical vein and just leave it patent? In the
supracardiacs, do you still ligate the vein? How do you manage
or avoid that problem?
Dr Alghamdi. Most of the infracardiac types have obstructed
vertical veins anyway, so it would be reasonable to just leave the
vertical vein alone. An alternative would be to ligate the vertical
vein from the inside of the confluence to avoid dissecting around
the vertical vein.
For the supracardiac type, it is not unreasonable to leave the ver-
tical vein alone if it is obstructed. Our approach has been to ligate
the vertical vein routinely.
In terms of the other bleeding complications, in a previous re-
port, in those with post-repair stenosis, where the incision of the
pulmonary vein extended toward the hilum of the lung, the integ-
rity of the pleuro-pericardial junction was violated, which resulted
in bleeding into the pleura space, and that was repaired by approx-
imation of that area between the hilum and the pleura.
Dr Manning. I would imagine in these cases you’re probably
not opening the veins as far out toward the hilum as you would
in a reoperative case as well.
Dr Alghamdi. That’s absolutely correct.
Dr Renato Assad (Sao Paulo, Brazil). In regard to an anticoa-
gulation protocol, do you recommend any antithrombotic therapy
for those patients undergoing a sutureless procedure for ‘‘simple’’
TAPVC?
Dr Alghamdi.One would think there is a raw surface in the left
heart side that may initiate some thromboembolic complications.
We do not have a standard protocol to anticoagulate these patients;
it is based on the surgeon’s discretion. Some surgeons would anti-
coagulate if they think the area of raw surface is extensive, and
others would not. But certainly we haven’t seen any thromboem-
bolic complications associated with this primary repair even in
the absence of anticoagulation.
Dr Assad. If you administer any antithrombotic therapy, how
long would you suggest continuing treatment?
Dr Alghamdi. Nobody knows. But what we do sometimes, and
that’s again based on the surgeon’s discretion, is continue treat-
ment for 6 weeks.diovascular Surgery c Volume 141, Number 6 1353
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DDr Assad. In regard to those patients who experienced progres-
sive pulmonary venous obstruction after primary repair, have you
given any endothelin-receptor antagonist or chemotherapy after
sutureless repair?
Dr Alghamdi. No.
Dr Assad. Is there any protocol with chemotherapy or Persan-
tine for those patients?
Dr Alghamdi. No, not at this time. Thank you!
Dr Zhou Hong (Wuhan, China). I have one question. In our
experience, I have had a case of TAPVC with a branch of the
PVS. In your opinion, can the sutureless procedure be used in these
patients?
Dr Alghamdi. If you had a TAPVC and the veins all drained
into the confluence and one of these veins was really small, what
we would do is open the confluence and extend the incision of
the confluence into the vein itself until it appears healthy and
then do the primary sutureless repair.1354 The Journal of Thoracic and Cardiovascular SurDr James Tweddell (Milwaukee, Wis). What if the stenosis
extends outside the pericardia?
Dr Alghamdi. As long as that integrity between the pericar-
dium and the pleura is intact, you can extend it toward the hilum
of the lung. Extension of such an incision too far is not without po-
tential risks. We have seen a similar patient (not part of this cohort)
with mixed-type TAPVD and very small veins. The incision was
extended into the hilum of the lungs. When the patient was trans-
ferred from the operating room to the intensive care unit, she re-
quired high-pressure ventilation because the lungs were very
stiff. The patient immediately collapsed and required an ECMO.
When the aortic cannula was inserted into the aorta, a significant
amount of air was seen inside the aorta in the form of froth. That
massive air embolism was possibly due to a communication with
the left atrium. The patient was on ECMO for a few days and
weaned successfully. She had a remarkable recovery with no sig-
nificant complications and was discharged.gery c June 2011
